{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T22:25:04Z","timestamp":1793485504771,"version":"4.5.0"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"4","funder":[{"DOI":"10.13039\/100017065","name":"Rogel Cancer Center, University of Michigan","doi-asserted-by":"publisher","award":["CA 046592"],"award-info":[{"award-number":["CA 046592"]}],"id":[{"id":"10.13039\/100017065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NCI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Androgen deprivation therapy (ADT) use is associated with an increased risk of developing depression and anxiety. Little is known about how the mental health of these men is treated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Materials and Methods<\/jats:title>\n                  <jats:p>We identified men with prostate cancer who received ADT between 2001 and 2015 using Optum\u2019s de-identified Clinformatics Data Mart Database. We determined the incidence of depression or anxiety diagnoses, mental health treatments, and the specialty of providers initiating psychotropic medications, after the start of ADT. Outcomes were compared with those of men with prostate cancer not receiving ADT and men without prostate cancer.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 37\u00a0388 men with prostate cancer treated with ADT, 3964 (10.6%) received a new diagnosis of depression or anxiety. Of those 3964 men, 1892 (47.7%) did not receive a documented treatment, 10 (0.3%) received psychotherapy, 1321 (33.3%) a selective serotonin reuptake inhibitor, and 744 (18.8%) a benzodiazepine. The median time from initiation of ADT to a depression or anxiety diagnosis was 9.3 months. Primary care physicians were the most common prescribers of psychotropic medications (72.2%). The proportion of men not receiving mental health treatments of interest (47.7%) was similar compared to men without prostate cancer (49.1%), but statistically significantly lower compared to men with prostate cancer not receiving ADT (52.7%).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In men with prostate cancer receiving ADT with a new diagnosis of depression or anxiety, nearly half are not receiving mental health care while one in five is introduced to a benzodiazepine. Further investigation toward improving the mental health care for men on ADT is needed.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/oncolo\/oyab033","type":"journal-article","created":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T05:00:52Z","timestamp":1641013252000},"page":"314-322","source":"Crossref","is-referenced-by-count":24,"title":["Depression, Anxiety, and Patterns of Mental Health Care Among Men With Prostate Cancer Receiving Androgen Deprivation Therapy"],"prefix":"10.1093","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8694-3186","authenticated-orcid":false,"given":"Phoebe A","family":"Tsao","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA"},{"name":"Veterans Affairs Health Services Research & Development, Center for Clinical Management and Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, USA"},{"name":"Institute of Health Policy and Innovation, University of Michigan Medical School, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S B","family":"Bohnert","sequence":"additional","affiliation":[{"name":"Veterans Affairs Health Services Research & Development, Center for Clinical Management and Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, USA"},{"name":"Institute of Health Policy and Innovation, University of Michigan Medical School, Ann Arbor, MI, USA"},{"name":"Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhramar","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Institute of Health Policy and Innovation, University of Michigan Medical School, Ann Arbor, MI, USA"},{"name":"Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E V","family":"Caram","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA"},{"name":"Veterans Affairs Health Services Research & Development, Center for Clinical Management and Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, MI, USA"},{"name":"Institute of Health Policy and Innovation, University of Michigan Medical School, Ann Arbor, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,3,17]]},"reference":[{"issue":"8","key":"2022040513513727400_CIT0001","first-page":"1333","article-title":"Mental health outcomes in elderly men with prostate cancer.","volume":"32","author":"Ravi","year":"2014","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"3","key":"2022040513513727400_CIT0002","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/pon.4579","article-title":"Understanding the distressed prostate cancer patient: role of personality.","volume":"27","author":"Perry","year":"2018","journal-title":"Psychooncology"},{"issue":"7","key":"2022040513513727400_CIT0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamanetworkopen.2019.6562","article-title":"Association between androgen deprivation therapy use and diagnosis of dementia in men with prostate cancer.","volume":"2","author":"Jayadevappa","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"6","key":"2022040513513727400_CIT0004","first-page":"647","article-title":"Prevalent and incident use of androgen deprivation therapy among men with prostate cancer in the United States.","volume":"29","author":"Gilbert","year":"2011","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"2022040513513727400_CIT0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(02)09408-4","article-title":"Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.","volume":"360","author":"Bolla","year":"2002","journal-title":"Lancet"},{"key":"2022040513513727400_CIT0006","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1200\/JCO.2007.14.9021","article-title":"Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer.","volume":"26","author":"Horwitz","year":"2008","journal-title":"J Clin Oncol."},{"key":"2022040513513727400_CIT0007","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.euf.2017.10.014","article-title":"Past, current, and future incidence rates and burden of metastatic prostate cancer in the United States.","volume":"4","author":"Kelly","year":"2018","journal-title":"Eur Urol Focus"},{"key":"2022040513513727400_CIT0008","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1200\/JCO.2015.64.1969","article-title":"Association of androgen deprivation therapy with depression in localized prostate cancer.","volume":"34","author":"Dinh","year":"2016","journal-title":"J Clin Oncol"},{"issue":"10","key":"2022040513513727400_CIT0009","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/iju.13409","article-title":"Association between androgen deprivation therapy and anxiety among 78,000 patients with localized prostate cancer.","volume":"24","author":"Dinh","year":"2017","journal-title":"Int J Urol"},{"key":"2022040513513727400_CIT0010","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/cncr.31982","article-title":"Androgen deprivation therapy and depression in men with prostate cancer treated with definitive radiation therapy.","volume":"125","author":"Deka","year":"2019","journal-title":"Cancer."},{"issue":"(12","key":"2022040513513727400_CIT0011","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/pon.4453","article-title":"Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: a 15-month prospective, observational study.","volume":"26","author":"Zhang","year":"2017","journal-title":"Psychooncology"},{"key":"2022040513513727400_CIT0012","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.clgc.2018.05.007","article-title":"Association between androgen deprivation therapy and patient-reported depression in men with recurrent prostate cancer.","volume":"16","author":"Thomas","year":"2018","journal-title":"Clin Genitourin Cancer."},{"issue":"11","key":"2022040513513727400_CIT0013","first-page":"664.e1","article-title":"Association of androgen deprivation therapy and depression in the treatment of prostate cancer: a systematic review and meta-analysis.","volume":"35","author":"Nead","year":"2017","journal-title":"Urol Oncol Semin Orig Investig"},{"issue":"10","key":"2022040513513727400_CIT0014","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.3390\/ijerph15102148","article-title":"Depression negatively impacts survival of patients with metastatic prostate cancer.","volume":"15","author":"Lin","year":"2018","journal-title":"Int J Env Res Public Heal"},{"issue":"3","key":"2022040513513727400_CIT0015","first-page":"352","article-title":"Psychological distress in men with prostate cancer receiving adjuvant androgen-deprivation therapy.","volume":"31","author":"Saini","year":"2013","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"2022040513513727400_CIT0016","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1038\/s41388-018-0177-4","article-title":"Depression promotes prostate cancer invasion and metastasis via a sympathetic-cAMP-FAK signaling pathway.","volume":"37","author":"heng","year":"2018","journal-title":"Oncogene."},{"issue":"9","key":"2022040513513727400_CIT0017","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/jgs.14424","article-title":"Association between depression and hospital admission in older men with prostate cancer.","volume":"64","author":"Laurence","year":"2016","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"2022040513513727400_CIT0018","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/pon.2032","article-title":"The burden of depression in prostate cancer.","volume":"21","author":"Jayadevappa","year":"2012","journal-title":"Psychooncology"},{"key":"2022040513513727400_CIT0019","volume-title":"Data Mart User Manual, Version 7.1","author":"Clinformatics\u00ae","year":"2017"},{"key":"2022040513513727400_CIT0020","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jad.2016.12.033","article-title":"Major depressive disorder with subthreshold hypomanic (mixed) features: a real-world assessment of treatment patterns and economic burden.","volume":"210","author":"McIntyre","year":"2017","journal-title":"J Affect Disord."},{"key":"2022040513513727400_CIT0021","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00005392-199907000-00024","article-title":"Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer.","volume":"162","author":"Quella","year":"1999","journal-title":"J Urol."},{"key":"2022040513513727400_CIT0022","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM199710233371703","article-title":"A comparison of sustained-release bupropion and placebo for smoking cessation.","volume":"337","author":"Hurt","year":"1997","journal-title":"N Engl J Med"},{"key":"2022040513513727400_CIT0023","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S2215-0366(14)70313-X","article-title":"Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data.","volume":"1","author":"Walker","year":"2014","journal-title":"Lancet Psychiatry."},{"key":"2022040513513727400_CIT0024","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jpainsymman.2018.11.024","article-title":"Opportunities to improve detection and treatment of depression among patients with breast cancer treated in an integrated delivery system.","volume":"57","author":"Check","year":"2019","journal-title":"J Pain Symptom Manage."},{"key":"2022040513513727400_CIT0025","doi-asserted-by":"crossref","first-page":"e1098","DOI":"10.1634\/theoncologist.2019-0709","article-title":"Gaps in the management of depression symptoms following cancer diagnosis: a population-based analysis of prospective patient-reported outcomes.","volume":"25","author":"Hallet","year":"2020","journal-title":"Oncologist."},{"issue":"12","key":"2022040513513727400_CIT0026","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1002\/cncr.21532","article-title":"Psychiatric disorders and mental health service use in patients with advanced cancer: a report from the coping with cancer study.","volume":"104","author":"Kadan-Lottick","year":"2005","journal-title":"Cancer"},{"key":"2022040513513727400_CIT0027","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1200\/JCO.2007.15.4864","article-title":"Predictors of referral for specialized psychosocial oncology care in patients with metastatic cancer: the contributions of age, distress, and marital status.","volume":"27","author":"Ellis","year":"2009","journal-title":"J Clin Oncol"},{"key":"2022040513513727400_CIT0028","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1200\/JCO.2005.08.041","article-title":"Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecologic cancer.","volume":"23","author":"Ell","year":"2005","journal-title":"J Clin Oncol."},{"issue":"suppl 1","key":"2022040513513727400_CIT0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-244X-14-S1-S1","article-title":"Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.","volume":"14","author":"Katzman","year":"2014","journal-title":"BMC Psychiatry"},{"key":"2022040513513727400_CIT0030","author":"National Institute for Health and Clinical Excellence."},{"issue":"11","key":"2022040513513727400_CIT0031","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1111\/jgs.13702","article-title":"American Geriatrics Society 2015 Updated Beers Criteria for potentially inappropriate medication use in older adults","volume":"63","author":"American Geriatrics Society 2015 Beers Criteria Update Expert Panel.","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"suppl 2","key":"2022040513513727400_CIT0032","first-page":"9","article-title":"The effects of benzodiazepines on cognition.","volume":"66","author":"Stewart","year":"2005","journal-title":"J Clin Psychiatry."},{"issue":"21","key":"2022040513513727400_CIT0033","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1001\/archinternmed.2009.357","article-title":"Meta-analysis of the impact of nine medication classes on falls in elderly persons.","volume":"169","author":"Woolcott","year":"2009","journal-title":"Arch Intern Med"},{"issue":"6","key":"2022040513513727400_CIT0034","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1176\/appi.ajp.158.6.892","article-title":"Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture.","volume":"158","author":"Wang","year":"2001","journal-title":"Am J Psychiatry"},{"issue":"2","key":"2022040513513727400_CIT0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2165\/11539050-000000000-00000","article-title":"Effects of benzodiazepines, antidepressants and opioids on driving.","volume":"34","author":"Dassanayake","year":"2011","journal-title":"Drug Saf"},{"issue":"4","key":"2022040513513727400_CIT0036","doi-asserted-by":"crossref","first-page":"e202051","DOI":"10.1001\/jamanetworkopen.2020.2051","article-title":"Association of Medicare Part D benzodiazepine coverage expansion with changes in fall-related injuries and overdoses among Medicare Advantage beneficiaries.","volume":"3","author":"Maust","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2022040513513727400_CIT0037","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12888-019-2418-7","article-title":"Treatment patterns and sequences of pharmacotherapy for patients diagnosed with depression in the United States: 2014 through 2019.","volume":"20","author":"Kern","year":"2020","journal-title":"BMC Psychiatry"},{"issue":"4","key":"2022040513513727400_CIT0038","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/01.mlr.0000204287.82701.9b","article-title":"Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes.","volume":"44","author":"Cantrell","year":"2006","journal-title":"Med Care"},{"issue":"6","key":"2022040513513727400_CIT0039","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1176\/ajp.149.6.795","article-title":"Pattern of recurrence of illness after recovery from an episode of major depression: a prospective study.","volume":"149","author":"Maj","year":"1992","journal-title":"Am J Psychiatry"},{"issue":"12","key":"2022040513513727400_CIT0040","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1001\/archpsyc.55.12.1128","article-title":"The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression.","volume":"55","author":"Melfi","year":"1998","journal-title":"Arch Gen Psychiatry"},{"key":"2022040513513727400_CIT0041","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.15585\/mmwr.mm6941a1","article-title":"Prostate cancer incidence and survival, by stage and race\/ethnicity\u2014United States, 2001-2017.","volume":"69","author":"Siegel","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022040513513727400_CIT0042","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s00520-010-1004-9","article-title":"Identifying tumor patients\u2019 depression.","volume":"19","author":"Singer","year":"2011","journal-title":"Support Care Cancer"},{"issue":"8","key":"2022040513513727400_CIT0043","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1054\/bjoc.2001.1724","article-title":"Psychiatric morbidity and its recognition by doctors in patients with cancer.","volume":"84","author":"Fallowfield","year":"2001","journal-title":"Br J Cancer"},{"key":"2022040513513727400_CIT0044","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2147\/NDT.S128584","article-title":"Racial and ethnic differences in depression: current perspectives.","volume":"15","author":"Bailey","year":"2019","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2022040513513727400_CIT0045","volume-title":"A Long Road Ahead: Achieving True Parity in Mental Health and Substance Use Care","author":"National Alliance on Mental Illness","year":"2015"},{"issue":"2","key":"2022040513513727400_CIT0046","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/jamapsychiatry.2013.2862","article-title":"Acceptance of insurance by psychiatrists and the implications for access to mental health care.","volume":"71","author":"Bishop","year":"2014","journal-title":"JAMA Psychiatry"},{"issue":"24","key":"2022040513513727400_CIT0047","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1002\/cncr.29672","article-title":"Psychological effects of androgen-deprivation therapy on men with prostate cancer and their partners.","volume":"121","author":"Donovan","year":"2015","journal-title":"Cancer"},{"issue":"10","key":"2022040513513727400_CIT0048","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.6004\/jnccn.2019.0048","article-title":"Distress management, version 3.2019.","volume":"17","author":"Riba","year":"2019","journal-title":"J Natl Compre Canc Netw"},{"issue":"26","key":"2022040513513727400_CIT0049","doi-asserted-by":"crossref","first-page":"6440","DOI":"10.1200\/JCO.2005.02.3259","article-title":"Emotional distress: the sixth vital sign in cancer care.","volume":"23","author":"Bultz","year":"2005","journal-title":"J Clin Oncol"},{"issue":"32","key":"2022040513513727400_CIT0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jncimonographs\/lgh019","article-title":"Barriers to the treatment of depression in cancer patients.","author":"Greenberg","year":"2004","journal-title":"J Natl Cancer Inst Monogr"},{"key":"2022040513513727400_CIT0051","volume-title":"National Projections of Supply and Demand for Behavioral Health Practitioners: 2013-2015","author":"Health Resources and Services Administration\/National Center for Health Workforce Analysis; Substance Abuse and Mental Health Services Administration\/Office of Policy, Planning, and Innovation","year":"2015"},{"issue":"6","key":"2022040513513727400_CIT0052","doi-asserted-by":"crossref","first-page":"S199","DOI":"10.1016\/j.amepre.2018.01.004","article-title":"Geographic variation in the supply of selected behavioral health providers.","volume":"54","author":"Andrilla","year":"2018","journal-title":"Am J Prev Med"},{"key":"2022040513513727400_CIT0053","volume-title":"Dissemination of Integrated Care Within Adult Primary Care Settings: The Collaborative Care Model.","author":"American Psychiatric Association and Academy of Psychosomatic Medicine.","year":"2016"},{"key":"2022040513513727400_CIT0054","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/pon.4286","article-title":"Systematic review and meta-analysis of collaborative care interventions for depression in patients with cancer.","volume":"26","author":"Li","year":"2017","journal-title":"Psychooncology"},{"key":"2022040513513727400_CIT0055","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1200\/JCO.2011.39.7398","article-title":"Integrating psychosocial care into cancer services.","volume":"30","author":"Fann","year":"2012","journal-title":"J Clin Oncol."},{"issue":"5","key":"2022040513513727400_CIT0056","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2710.2005.00674.x","article-title":"Achieving a sustained reduction in benzodiazepine use through implementation of an area-wide multi-strategic approach.","volume":"30","author":"Dollman","year":"2005","journal-title":"J Clin Pharm Ther"},{"issue":"6","key":"2022040513513727400_CIT0057","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial.","volume":"174","author":"Tannenbaum","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2022040513513727400_CIT0058","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s11606-009-1058-x","article-title":"The role of primary care physicians in cancer care.","volume":"24","author":"Klabunde","year":"2009","journal-title":"J Gen Intern Med."},{"issue":"27","key":"2022040513513727400_CIT0059","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.1200\/JCO.2005.05.026","article-title":"Communication and coordination: the keys to quality.","volume":"23","author":"Schrag","year":"2005","journal-title":"J Clin Oncol"},{"key":"2022040513513727400_CIT0060","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1056\/NEJMhpr0706165","article-title":"Coordinating care\u2014a perilous journey through the health care system.","volume":"358","author":"Bodenheimer","year":"2008","journal-title":"N Engl J Med."}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/27\/4\/314\/43287397\/oyab033.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/27\/4\/314\/43287397\/oyab033.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T13:53:23Z","timestamp":1649166803000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/27\/4\/314\/6550091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,17]]},"references-count":60,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,3,17]]},"published-print":{"date-parts":[[2022,4,5]]}},"URL":"https:\/\/doi.org\/10.1093\/oncolo\/oyab033","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,1]]},"published":{"date-parts":[[2022,3,17]]}}}